MedPath

Sodium Bicarbonate for the prevention of contrast induced nephropathy in patients suspected with acute pulmonary embolism undergoing CTPA.

Recruiting
Conditions
Contrast Induced Nephropathy (contrastnefropathie)CT-pulmonary angiography (CTPA)Sodium bicarbonate (natriumbicarbonaat)Prevention (preventie)
Registration Number
NL-OMON25804
Lead Sponsor
ame: Judith KooimanAddress: Leiden University Medical Center, Albinusdreef 2, Postzone C4-70, 2333 ZA Leiden, The Netherlandsemail: j.kooiman@lumc.nltel: +31 (0)71-526.20.85
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
264
Inclusion Criteria

Clinical suspected PE with an indication for CT-PA with intravenous administration of iso-osmolair contrast media and eGFR < 60 ml/min.

Exclusion Criteria

1. Age < 18 years;

2. Exposure to contrast media within 7 days;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mean increase in serumcreatinine 2-4 days after CT-PA.
Secondary Outcome Measures
NameTimeMethod
1. Increase in serum creatinine > 25% or > 44 umol/l, 3 days (+/- 1 day) after CT-PA with contrast media;<br /><br>2. Increase in serum creatinine >25% or > 44 umol/l 2 months after CTPA with contrast media or the need for dialysis;<br /><br>3. Increase in C-cystatine and NGAL 3 days (+/- 1 day) after CT-PA;<br /><br>4. Increase in NGAL 2 hours after CT-PA.
© Copyright 2025. All Rights Reserved by MedPath